Clene Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for CLNN, updated each market day.
CLNN AI Sentiment
AI predicts Clene Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Clene Inc. Common Stock
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Sector
Exchange
Market Cap
$58,988,021
Cap Tier
Employees
79
Headquarters
SALT LAKE CITY, UT
Listed Since
Dec. 31, 2020
Website
CLNN Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CLNN Volatility
Clene Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
